# Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

> **NCT00001061** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 167 (—)

## Conditions studied

- Cytomegalovirus Retinitis
- HIV Infections

## Interventions

- **DRUG:** Sevirumab
- **DRUG:** Foscarnet sodium
- **DRUG:** Ganciclovir

## Key facts

- **NCT ID:** NCT00001061
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1998-03
- **Target enrollment:** 167 (—)
- **Last updated:** 2021-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001061, "Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT00001061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*